10-Q 1 l73019110q.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

(Mark One)

 

☑   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
     
For the quarterly period ended June 30, 2019
☐    
  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from __________ to __________

 

Commission file number: 000-50081

 

UNIROYAL GLOBAL ENGINEERED PRODUCTS, INC.

(Name of registrant as specified in its charter)

 

Nevada   65-1005398
(State or Other Jurisdiction of Organization)   (IRS Employer Identification Number)
     

 

1800 2nd Street, Suite 970

Sarasota, FL 34236

(Address of principal executive offices)

 

(941) 906-8580

(Issuer’s telephone number)

 

 

Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑    No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ☑ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

  Large accelerated filer    ☐ Accelerated filer    ☐  
  Non-accelerated filer    ☑ Smaller reporting company    ☑  
  Emerging growth company    ☐    

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☑

 

Securities registered under Section 12(b) of the Act: None.

 

As of August 1, 2019, the issuer had 17,060,928 shares of ordinary Common Stock, $0.001 par value, and 1,619,102 shares of Class B Common Stock, $0.001 par value, outstanding.

 

 

 

   
 

 

UNIROYAL GLOBAL ENGINEERED PRODUCTS, INC.

 

Form 10-Q

Table of Contents

 

 

  Page
   
Cautionary Note Regarding Forward-Looking Statements 3
   
PART I.  FINANCIAL INFORMATION
     
Item 1. Financial Statements 4
     
  Consolidated Balance Sheets 4
  Consolidated Statements of Operations 5
  Consolidated Statements of Comprehensive Loss 6
  Consolidated Statements of Changes in Stockholders’ Equity 7
  Consolidated Statements of Cash Flows 8
  Notes to Consolidated Financial Statements 9
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 20
     
Item 3. Quantitative and Qualitative Disclosures About Market Risk 25
   
Item 4. Controls and Procedures 26
     
PART II.  OTHER INFORMATION
     
Item 1. Legal Proceedings 27
     
Item 1A. Risk Factors 27
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 27
     
Item 3. Defaults Upon Senior Securities 27
     
Item 4. Mine Safety Disclosures 27
     
Item 5. Other Information 27
     
Item 6. Exhibits 28
     
Signatures 28

 

   

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

Except for statements of historical fact, certain information contained herein constitutes forward-looking statements including, without limitation, statements containing the words “believes,” “anticipates,”  “intends,” “expects,” and words of similar import, as well as all references to future results. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results or achievements of Uniroyal Global Engineered Products, Inc. to be materially different from any future results or achievements expressed or implied by such forward-looking statements. Such factors include, but are not limited to, the following: risks involved in implementing our business strategy, our ability to obtain financing on acceptable terms, competition, our ability to manage growth, pricing and availability of equipment, materials and inventories, performance issues with suppliers, economic growth, the Company’s ability to successfully integrate acquired operations, currency fluctuations, risks of technological change, the effectiveness of cost-reduction plans, our dependence on key personnel, our ability to protect our intellectual property rights, risks of new technology and new products, and government regulation. All forward-looking statements are qualified in their entirety by this cautionary statement, and the Company undertakes no obligation to revise or update any such forward-looking statements to reflect events, developments or circumstances after the date hereof.

 

 

  3 

 

Part 1 - FINANCIAL INFORMATION

 

Item 1 - Financial Statements

 

Uniroyal Global Engineered Products, Inc.

Consolidated Balance Sheets

 

   (Unaudited)   
       
ASSETS  June 30, 2019  December 30, 2018
CURRENT ASSETS          
Cash and cash equivalents  $724,198   $1,028,841 
Accounts receivable, net   14,130,970    12,422,330 
Inventories, net   19,900,278    19,460,260 
Other current assets   780,573    965,520 
Related party receivable   28,963    20,118 
Total Current Assets   35,564,982    33,897,069 
           
PROPERTY AND EQUIPMENT, NET   25,618,778    18,878,949 
           
OTHER ASSETS          
Intangible assets   3,209,574    3,217,997 
Goodwill   1,079,175    1,079,175 
Other long-term assets   3,723,620    3,693,367 
Total Other Assets   8,012,369    7,990,539 
TOTAL ASSETS  $69,196,129   $60,766,557 
           
LIABILITIES AND STOCKHOLDERS' EQUITY          
CURRENT LIABILITIES          
Checks issued in excess of bank balance  $765,612   $855,210 
Lines of credit   21,196,050    19,325,116 
Current maturities of long-term debt   1,478,311    1,369,967 
Current maturities of finance lease liabilities   275,958    388,862 
Accounts payable   9,687,140    9,335,235 
Accrued expenses and other liabilities   4,147,493    3,326,291 
Related party obligation   126,313    84,154 
Current portion of postretirement benefit liability - health and life   139,095    139,095 
Total Current Liabilities   37,815,972    34,823,930 
           
LONG-TERM LIABILITIES          
Long-term debt, less current portion   3,681,760    3,967,754 
Finance lease liabilities, less current portion   22,625    109,446 
Related party lease financing obligation   2,712,003    2,613,717 
Long-term debt to related parties   3,190,655    2,990,655 
Postretirement benefit liability - health and life, less current portion   2,089,154    2,101,892 
Other long-term liabilities   6,842,712    653,653 
Total Long-Term Liabilities   18,538,909    12,437,117 
Total Liabilities   56,354,881    47,261,047 
           
STOCKHOLDERS' EQUITY          
Preferred units, Series A UEP Holdings, LLC, 200,000 units issued
         and outstanding ($100 issue price)		   617,571    617,571 

Preferred units, Series B UEP Holdings, LLC, 150,000 units issued
         and outstanding ($100 issue price)

   463,179    463,179 

Preferred stock, Uniroyal Global (Europe) Limited, 50 shares
         issued and outstanding ($1.51 stated value)

   75    75 

Common stock, 95,000,000 shares authorized ($.001 par value)
         18,680,030 and 18,690,030 shares issued and outstanding as of
         June 30, 2019 and December 30, 2018, respectively

   18,680    18,690 
Additional paid-in capital   35,275,646    35,244,770 
Accumulated deficit   (22,702,471)   (22,136,130)
Accumulated other comprehensive loss   (831,432)   (702,645)
Total Stockholders' Equity   12,841,248    13,505,510 
           
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY  $69,196,129   $60,766,557 

 

See accompanying notes to the consolidated financial statements.

 

  4 

 

Uniroyal Global Engineered Products, Inc.

Consolidated Statements of Operations

(Unaudited)

 

   Three Months Ended  Six Months Ended
   June 30, 2019  July 1, 2018  June 30, 2019  July 1, 2018
             
NET SALES  $24,095,783   $26,023,233   $49,489,643   $52,452,920 
                     
COST OF GOODS SOLD   19,883,392    21,259,055    40,963,050    43,071,248 
                     
Gross Profit   4,212,391    4,764,178    8,526,593    9,381,672 
                     
OPERATING EXPENSES:                    
Selling   1,183,803    1,200,051    2,286,841    2,549,081 
General and administrative   1,449,060    1,658,665    2,959,860    3,606,966 
Research and development   447,754    430,565    924,718    852,528 
Other operating expenses   —      —      343,003    —   
OPERATING EXPENSES   3,080,617    3,289,281    6,514,422    7,008,575 
                     
Operating Income   1,131,774    1,474,897    2,012,171    2,373,097 
                     
OTHER EXPENSE:                    
Interest and other debt related expense   (523,218)   (473,663)   (1,037,514)   (930,027)
Other income (expense)   (224,950)   (19,220)   3,183    14,062 
Net Other Expense   (748,168)   (492,883)   (1,034,331)   (915,965)
                     
INCOME BEFORE TAX PROVISION   383,606    982,014    977,840    1,457,132 
                     
TAX PROVISION (BENEFIT)   20,559    57,521    (18,309)   43,000 
                     
NET INCOME   363,047    924,493    996,149    1,414,132 
                     
Preferred stock dividend   (779,946)   (776,104)   (1,562,490)   (1,560,563)
                     
NET INCOME (LOSS) ALLOCABLE TO COMMON
 SHAREHOLDERS		  $(416,899)  $148,389   $(566,341)  $(146,431)
                     
                     
INCOME (LOSS) PER COMMON SHARE:                    
Basic  $(0.02)  $0.01   $(0.03)  $(0.01)
Diluted  $(0.02)  $0.01   $(0.03)  $(0.01)
WEIGHTED AVERAGE SHARES OUTSTANDING:                    
Basic   18,684,755    18,690,030    18,687,393    18,690,030 
Diluted   18,684,755    18,690,030    18,687,393    18,690,030 

 

See accompanying notes to the consolidated financial statements.

 

  5 

 

Uniroyal Global Engineered Products, Inc.

Consolidated Statements of Comprehensive Loss

(Unaudited)

 

   Three Months Ended  Six Months Ended
   June 30, 2019  July 1, 2018  June 30, 2019  July 1, 2018
             
NET INCOME  $363,047   $924,493   $996,149   $1,414,132 
                     
OTHER COMPREHENSIVE LOSS:                    
Minimum benefit liability adjustment   (73,617)   (29,931)   (147,234)   (59,462)
Foreign currency translation adjustment   (254,674)   (776,546)   18,447    (292,978)
OTHER COMPREHENSIVE LOSS   (328,291)   (806,477)   (128,787)   (352,440)
                     
COMPREHENSIVE INCOME   34,756    118,016    867,362    1,061,692 
                     
Preferred stock dividend   (779,946)  (776,104)  (1,562,490)  (1,560,563)
                     
COMPREHENSIVE LOSS TO COMMON
SHAREHOLDERS		  $(745,190)  $(658,088)  $(695,128)  $(498,871)

 

See accompanying notes to the consolidated financial statements.

 

  6 

 

Uniroyal Global Engineered Products, Inc.

Consolidated Statements of Changes in Stockholders' Equity

(Unaudited)

 

   UEPH Series A  UEPH Series B  UGEL Preferred  Common Stock  Additional Paid  Accumulated  Accumulated
Other
Comprehensive
Income		   
   Units  Amount  Units  Amount  Shares  Amount  Shares  Amount  In Capital  Deficit  (Loss)  Total Equity
For the Three Months Ended                                                        
July 1, 2018                                                        
Balance April 1, 2018  200,000   $617,571   150,000   $463,179   50   $75   18,690,030   $18,690   $35,044,933   $(20,571,764)  $78,885   $15,651,569 
Net income  —      —     —      —     —      —     —      —      —      924,493    —      924,493 
Other comprehensive loss  —      —     —      —     —      —     —      —      —      —      (806,477)   (806,477)
Stock-based compensation
 expense		  —      —     —      —     —      —     —      —      93,420    —      —      93,420 
Preferred stock dividend  —      —     —      —     —      —     —      —      —      (776,104)   —      (776,104)
Balance July 1, 2018  200,000   $617,571   150,000   $463,179   50   $75   18,690,030   $18,690   $35,138,353   $(20,423,375)  $(727,592)  $15,086,901 
                                                         
                                                         
For the Three Months Ended                                                        
June 30, 2019                                                        
Balance March 31, 2019  200,000   $617,571   150,000   $463,179   50   $75   18,690,030   $18,690   $35,288,936   $(22,285,572)  $(503,141)  $13,599,738 
Net income  —      —     —      —     —      —     —      —      —      363,047    —      363,047 
Other comprehensive loss  —      —     —      —     —      —     —      —      —      —      (328,291)   (328,291)
Treasury shares purchased at
 cost and retired		  —      —     —      —     —      —     (10,000)   (10)   (13,290)   —      —      (13,300)
Preferred stock dividend  —      —     —      —     —      —     —      —      —      (779,946)   —      (779,946)
Balance June 30, 2019  200,000   $617,571   150,000   $463,179   50   $75   18,680,030   $18,680   $35,275,646   $(22,702,471)  $(831,432)  $12,841,248 
                                                         
                                                         
For the Six Months Ended                                                        
July 1, 2018                                                        
Balance December 31, 2017  200,000   $617,571   150,000   $463,179   50   $75   18,690,030   $18,690    34,944,972   $(20,276,944)  $(375,152)  $15,392,391 
Net income  —      —     —      —     —      —     —      —      —      1,414,132    —      1,414,132 
Other comprehensive loss  —      —     —      —     —      —     —      —      —      —      (352,440)   (352,440)
Stock-based compensation
 expense		  —      —     —      —     —      —     —      —      193,381    —      —      193,381 
Preferred stock dividend  —      —     —      —     —      —     —      —      —      (1,560,563)   —      (1,560,563)
Balance July 1, 2018  200,000   $617,571   150,000   $463,179   50   $75   18,690,030   $18,690   $35,138,353   $(20,423,375)  $(727,592)  $15,086,901 
                                                         
                                                         
For the Six Months Ended                                                        
June 30, 2019                                                        
Balance December 30, 2018  200,000   $617,571   150,000   $463,179   50   $75   18,690,030   $18,690   $35,244,770   $(22,136,130)  $(702,645)  $13,505,510 
Net income  —      —     —      —     —      —     —      —      —      996,149    —      996,149 
Other comprehensive loss  —      —     —      —     —      —     —      —      —      —      (128,787)   (128,787)
Stock-based compensation
 expense		  —      —     —      —     —      —     —      —      44,166    —      —      44,166 
Treasury shares purchased at
 cost and retired		  —      —     —      —     —      —     (10,000)   (10)   (13,290)   —      —      (13,300)
Preferred stock dividend  —      —     —      —     —      —     —      —      —      (1,562,490)   —      (1,562,490)
Balance June 30, 2019  200,000   $617,571   150,000   $463,179   50   $75   18,680,030   $18,680   $35,275,646   $(22,702,471)  $(831,432)  $12,841,248 

 

See accompanying notes to the consolidated financial statements.

 

  7 

 

Uniroyal Global Engineered Products, Inc.

Consolidated Statements of Cash Flows

(Unaudited)

 

   Six Months Ended
CASH FLOWS FROM OPERATING ACTIVITIES  June 30, 2019  July 1, 2018
       
Net income  $996,149   $1,414,132 
Adjustments to reconcile net income to net cash flows from operating activities:          
Depreciation   1,187,029    1,063,767 
Stock-based compensation expense   44,166    193,381 
Amortization of intangible assets   9,167    10,002 
Loss on disposal of property and equipment   65,542    6,523 
Noncash postemployment health and life benefit   (147,234)   (59,462)
Noncash lease expense   (49,250)   —   
Changes in assets and liabilities:          
Accounts receivable   (1,719,059)   (1,160,237)
Inventories   (447,340)   144,368 
Other current assets   188,017    (47,082)
Related party receivable   (8,845)   35,043 
Other long-term assets   57,572    (40,223)
Accounts payable   370,722    187,557 
Accrued expenses and other liabilities   275,278    361,493 
Postretirement benefit liability - health and life   (12,738)   (24,815)
Other long-term liabilities   (3,703)   (16,541)
Cash provided by operating activities   805,473    2,067,906 
           
CASH FLOWS FROM INVESTING ACTIVITIES          
Capital expenditures   (738,944)   (1,277,121)
Payments on life insurance policies, net of policy loan activity   (87,699)   (106,163)
Cash used in investing activities   (826,643)   (1,383,284)
           
CASH FLOWS FROM FINANCING ACTIVITIES          
Net change in checks issued in excess of bank balance   (89,598)   18,681 
Net advances on lines of credit   1,707,469    389,712 
Payments on long-term debt   (472,112)   (436,276)
Proceeds from issuance of long-term debt   193,454    486,067 
Payments on finance lease liabilities   (203,710)   (205,199)
Net change in related party obligation   150,445    259,740 
Payment of preferred stock dividends   (1,560,822)   (1,553,806)
Purchase and retirement of treasury stock   (13,300)   —   
Cash used in financing activities   (288,174)   (1,041,081)
Net change in cash and cash equivalents   (309,344)   (356,459)
Cash and cash equivalents - beginning of period   1,028,841    1,267,319 
Effects of currency translation on cash and cash equivalents   4,701    (7,778)
           
CASH AND CASH EQUIVALENTS - END OF PERIOD  $724,198   $903,082 

 

See Note 2 for noncash transactions and supplemental disclosure of cash flow information.

 

See accompanying notes to the consolidated financial statements.

 

  8 

 

UNIROYAL GLOBAL ENGINEERED PRODUCTS, INC.

 

Notes to Consolidated Financial Statements

June 30, 2019

(Unaudited) 

 

 

  1. Basis of Presentation

 

The accompanying unaudited interim consolidated financial statements have been prepared based upon U.S. Securities and Exchange Commission rules that permit reduced disclosure for interim periods. Therefore, they do not include all information and footnote disclosures necessary for a complete presentation of Uniroyal Global Engineered Products, Inc.’s financial position, results of operations and cash flows, in conformity with generally accepted accounting principles. Uniroyal Global Engineered Products, Inc. (the “Company,” “Uniroyal Global,” “we,” or “us”) filed audited consolidated financial statements as of and for the fiscal years ended December 30, 2018 and December 31, 2017 which included all information and notes necessary for such complete presentation in conjunction with its 2018 Annual Report on Form 10-K.

 

The results of operations for the interim period ended June 30, 2019 are not necessarily indicative of the results to be expected for any future period or the entire fiscal year. These interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements for the year ended December 30, 2018, which are contained in the Company’s 2018 Annual Report on Form 10-K.

 

The Company owns all of the ownership interests in Uniroyal Engineered Products, LLC (“Uniroyal”) and its holding company UEP Holdings, LLC (“UEPH”), a U.S. manufacturer of textured coatings, and all of the ordinary common stock of Uniroyal Global (Europe) Limited (“UGEL”) formerly known as Engineered Products Acquisition Limited (“EPAL”), the holding company for Uniroyal Global Limited (“UGL”) formerly Wardle Storeys (Earby) Limited (“Wardle Storeys”), a European manufacturer of textured coatings and polymer films.

 

The Company and its subsidiaries use a 52/53-week fiscal year ending on the Sunday nearest to December 31. The current year ending December 29, 2019 and the prior year ended December 30, 2018 are 52-week years.

 

The accompanying unaudited interim consolidated financial statements contain all adjustments (consisting of normal recurring items) which are, in the opinion of management, necessary for a fair presentation of the Company’s financial position as of June 30, 2019 and the results of operations, comprehensive loss and cash flows for the interim periods ended June 30, 2019 and July 1, 2018.

 

The unaudited interim consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. The Company uses the U.S. dollar as the reporting currency for financial reporting. The financial position and results of operations of the Company’s U.K.-based operations are measured using the British Pound Sterling as the functional currency. See Note 5, Foreign Currency Translation.

 

  2. Noncash Transactions and Supplemental Disclosure of Cash Flow Information

 

During the six months ended June 30, 2019 and July 1, 2018, the Company paid down $171,758 and $203,173, respectively, of its term loans using available borrowings on its various lines of credit.

 

During the six months ended June 30, 2019 and July 1, 2018, the Company entered into several equipment financing obligations with fair values of $460,900 and $793,001, respectively, which are accounted for as capital assets. The fair values were added to property and equipment and a corresponding amount to finance lease or long-term debt. See Note 12 for additional information on finance leases.

 

The Company adopted Accounting Standards Update (“ASU”) No. 2016-02, “Leases” on December 31, 2018. Under this new standard, the Company was required to record on its balance sheet previously unrecorded operating leases based on the present value of remaining lease payments. Per this new standard, the Company recorded right-of-use (“ROU”) operating lease assets and operating lease liabilities of $6,911,550 on its consolidated balance sheet as of December 31, 2018. During the six months ended June 30, 2019, the Company recorded new lease ROU operating lease assets and operating lease liabilities of $287,828, amortization of its ROU operating lease assets of $303,009 and amortization of its operating lease liabilities of $352,259. See Note 12 for additional information on operating leases.

 

  9 

 

On April 1, 2018, the Company’s majority shareholder purchased the company owned life insurance policy on his life. The policy had a net value of $128,399 based on the cash surrender value of $578,490 and a policy loan outstanding in the amount of $450,091. After his assumption of a related party demand note payable in the amount of $125,000, the balance due of $3,399 was paid on April 17, 2018.

 

Supplemental disclosure of cash paid for the six months ended:

 

   June 30, 2019   July 1, 2018 
         
Interest expense  $984,956   $892,641 
           
Income taxes  $-   $- 

 

  3. Derivatives

 

The Company recognizes all of its derivative instruments as either assets or liabilities in the balance sheet at fair value. The accounting for changes in the fair value of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and further, as to whether the hedge is a cash flow hedge or a fair value hedge.

 

The Company incurs foreign currency risk on sales and purchases denominated in other currencies, primarily the British Pound Sterling and the Euro. Foreign currency exchange contracts are used by the Company principally to limit the exchange rate fluctuations of the Euro. The Euro risk is partially limited due to natural cash flow offsets. Currency exchange contracts are purchased for approximately 25% of the net risk. These contracts are not designated as cash flow hedges for accounting purposes. Changes in fair value of these contracts are reported in Other Income (Expense) in the accompanying Consolidated Statements of Operations.

 

  4. Fair Value of Financial Instruments

 

The Company’s short-term financial instruments consist of cash and cash equivalents, accounts receivable, accounts payable and lines of credit. The Company adjusts the carrying value of financial instruments denominated in other currencies such as cash, receivables, accounts payable and lines of credit using the appropriate exchange rates at the balance sheet date. The Company believes that the carrying values of these short-term financial instruments approximate their estimated fair values.

 

The fair value of the Company’s long-term debt is estimated based on current rates for similar instruments with the same remaining maturities. In determining the current interest rates for similar instruments, the Company takes into account its risk of nonperformance. The Company believes that the carrying value of its long-term debt approximates its estimated fair value.

 

The Company uses foreign currency exchange contracts which are recorded at their estimated fair values in the accompanying Consolidated Balance Sheets. The fair values of the contracts at June 30, 2019 and December 30, 2018 were a net liability of $14,350 and $26,814, respectively, included in other current liabilities. The fair values of the currency exchange contracts are based upon observable market transactions of spot and forward rates.

 

For the six months ended June 30, 2019, there have been no changes in the application of valuation methods applied to similar assets and liabilities.

 

  5. Foreign Currency Translation

 

The financial position and results of operations of the Company’s foreign subsidiaries are measured using the local currency as the functional currency. Assets and liabilities of operations denominated in foreign currencies are translated into U.S. dollars at exchange rates in effect at the balance sheet date, while the capital accounts are translated at the historical rate for the date they were recognized. Revenues and expenses are translated at the weighted average exchange rates during the reporting period. The resulting translation gains and losses on assets and liabilities are recorded in accumulated other comprehensive income (loss) and are excluded from net income until realized through a sale or liquidation of the investment. Transaction gains and losses generated from the remeasurement of assets and liabilities denominated in currencies other than the functional currency of the Company’s foreign operations are included in Other Income (Expense) in the accompanying Consolidated Statements of Operations.

 

  10 

 

  6. Inventories

 

Inventories consist of the following:

 

   June 30, 2019   December 30, 2018 
         
Raw materials  $5,145,916   $5,863,762 
Work-in-process   5,441,204    5,040,582 
Finished goods   10,994,943    10,049,567 
    21,582,063    20,953,911 
Less:  Allowance for inventory obsolescence   (1,681,785)   (1,493,651)
           
Total Inventories  $19,900,278   $19,460,260 

 

  7. Other Long-term Assets

 

Other long-term assets consist of the following:

 

   June 30, 2019   December 30, 2018 
         
Deferred tax asset  $2,862,265   $2,899,634 
Other   861,355    793,733 
           
Total Other Long-term Assets  $3,723,620   $3,693,367 

 

  8. Other Long-term Liabilities

 

Other long-term liabilities consist of the following:

 

   June 30, 2019   December 30, 2018 
         
Deferred tax liability  $636,834   $640,219 
Operating lease liabilities   6,192,444    - 
Other   13,434    13,434 
           
Total Other Long-term Liabilities  $6,842,712   $653,653 

 

See Note 12 for additional information on operating lease liabilities.

 

  9. Lines of Credit

 

The Company’s Uniroyal subsidiary has available a $30,000,000 revolving line of credit financing agreement with Wells Fargo Capital Finance, LLC (“Uniroyal Line of Credit”), which matures on June 15, 2023. Interest is payable monthly at the Eurodollar rate plus 2.25% or Wells Fargo Capital Finance, LLC's prime rate at the Company's election on outstanding balances up to $6,000,000 and prime rate on amounts in excess of $6,000,000. Borrowings on the line of credit are subject to the underlying borrowing base specified in the agreement. The underlying borrowing base is currently determined based upon eligible accounts receivable, inventories and equipment. The line of credit is secured by substantially all of Uniroyal's assets and includes certain financial and restrictive covenants. The Company was in compliance with these covenants as of June 30, 2019.

 

The outstanding balance on the Uniroyal Line of Credit was $11,967,443 and $10,713,318 as of June 30, 2019 and December 30, 2018, respectively. The Company has classified the outstanding balance on this line of credit within current liabilities in the accompanying Consolidated Balance Sheets.

 

  11 

 

The Company’s U.K. subsidiary has available a £10,000,000 (approximately $12.7 million) revolving line of credit financing agreement with Lloyds Bank Commercial Finance Limited (“U.K. Line of Credit”), which is subject to a six-month notice by either party. The line has several tranches based on currency or underlying security. Interest is payable monthly at the base rate (U.K. LIBOR or Lloyds Bank Base Rate as published) plus 1.95% to 2.45% depending on the tranche. Borrowings on the line of credit are subject to the underlying borrowing base specified in the agreement. The underlying borrowing base is currently determined based upon eligible accounts receivable and inventories. The line of credit is secured by substantially all of the subsidiary's assets and includes certain financial and restrictive covenants. The Company was in compliance with these covenants as of June 30, 2019.

 

The outstanding balance on the U.K. Line of Credit was £7,270,570 and £6,787,260 ($9,228,607 and $8,611,798) as of June 30, 2019 and December 30, 2018, respectively. The Company has classified the outstanding balance on this line of credit within current liabilities in the accompanying Consolidated Balance Sheets. 

 

  10. Long-term Debt

 

Long-term debt consists of the following:

 

   Interest Rate  June 30, 2019   December 30, 2018 
            
Wells Fargo Capital Finance, LLC  Prime  $1,256,801   $1,413,898 
Kennet Equipment Leasing Limited  10.90%   343,961    451,173 
Regents Capital Corporation  6.20%-7.41%   1,208,746    1,058,305 
De Lage Landen Financial Services  7.35%   56,867    68,208 
Ford Motor Credit  4.31%   23,346    27,881 
Byline Financial Group  8.55%   -    5,913 
BB&T Equipment Finance Corporation  4.02%-5.12%   776,757    879,600 
Crown Credit Company  7.06%   12,753    - 
Lloyds Bank Commercial Finance Limited  LIBOR + 3.15%   -    14,380 
Lloyds Bank Commercial Finance Limited  LIBOR + 3.50%   1,345,323    1,344,801 
Lloyds Bank Commercial Finance Limited  4.23%   66,411    73,562 
Lloyds Bank Commercial Finance Limited  LIBOR + 3.50%   69,106    - 
       5,160,071    5,337,721 
Less: Current portion      (1,478,311)   (1,369,967)
Long-term Portion     $3,681,760   $3,967,754 

 

  11. Related Party Obligations

 

Long-term debt to related parties consists of the following:

 

   Interest Rate  June 30, 2019   December 30, 2018 
            
Senior subordinated promissory note  9.25%  $2,000,000   $2,000,000 
Senior secured promissory note  10.00%   765,655    765,655 
Subordinated secured promissory note  8.00%   225,000    225,000 
Subordinated secured promissory note  8.00%   200,000    - 
       3,190,655    2,990,655 
Less: Current portion      -    - 
Long-term Portion     $3,190,655   $2,990,655 

 

  12 

 

The Company has a lease financing obligation under which it leases its main U.S. manufacturing facility and certain other property from a related party lessor entity, owned by the Company’s majority shareholder. The lease financing obligation accrues interest at 14.95% and currently requires monthly principal and interest payments of $45,201, which are adjusted annually based on the consumer price index. The lease financing obligation matures on October 31, 2033. The Company has security deposits aggregating $267,500 held by the lessor entity.

 

The lease financing obligation consists of the following:

 

   June 30, 2019   December 30, 2018 
         
Related party lease financing obligation  $2,838,316   $2,697,871 
Less: Current portion   (126,313)   (84,154)
           
Long-term Portion  $2,712,003   $2,613,717 

 

The long-term portion of the lease financing obligation is shown in the accompanying Consolidated Balance Sheets as Related Party Lease Financing Obligation and the current portion as Related Party Obligation.

 

  12. Leases

 

The Company has operating leases for equipment and office facilities and finance leases for equipment. These leases expire from January 2020 through March 2039. Operating lease right-of-use assets are included in property and equipment, the current portion of operating lease liabilities is included in accrued expenses and other liabilities, and the long-term portion of operating lease liabilities is included in other long-term liabilities in the accompanying Consolidated Balance Sheet at June 30, 2019. Finance lease right-of-use assets are included in property and equipment, the current portion of finance lease liabilities is included in current maturities of finance lease liabilities, and the long-term portion of finance liabilities is included in finance lease liabilities, less current portion in the accompanying Consolidated Balance Sheet at June 30, 2019.

 

The Company determines whether its contracts are or contain leases at inception. Right-of-use assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease right-of-use assets and liabilities are recognized at the beginning date of a lease based on the present value of lease payments over the lease term. The Company uses its incremental borrowing rate based on information that is available at the beginning date of a lease to determine the present value of lease payments, since its leases generally do not provide an implicit rate. The terms of the Company’s leases may include options to extend or terminate a lease when it is reasonably certain that the Company will exercise that option. The Company’s lease agreements with lease and non-lease components are accounted for separately.

 

The components of lease expense for the three and six months ended June 30, 2019 are as follows:

 

   Three Months Ended   Six Months Ended 
   June 30, 2019   June 30, 2019 
         
Operating lease expense  $292,140   $564,204 
           
Finance lease expense:          
Amortization of right-of-use assets  $37,407   $77,305 
Interest on lease liabilities   4,799    11,036 
Total finance lease expense  $42,206   $88,341 

 

  13 

 

Cash paid for amounts included in the measurement of lease liabilities for the three and six months ended June 30, 2019 are as follows:

 

   Three Months Ended   Six Months Ended 
   June 30, 2019   June 30, 2019 
         
Operating cash flows from operating leases  $252,220   $497,813 
Operating cash flows from finance leases  $4,799   $11,036 
Financing cash flows from finance leases  $101,859   $203,710 

 

Right-of-use assets obtained in exchange for lease obligations for the three and six months ended June 30, 2019 are as follows:

 

 

   Three Months Ended   Six Months Ended 
   June 30, 2019   June 30, 2019 
         
Operating leases  $248,176   $287,828 
Financing leases  $-   $- 

 

Supplemental balance sheet information related to operating leases is as follows:

 

   June 30, 2019 
Operating leases:     
Property and equipment, net  $6,787,022 
Accrued expenses and other liabilities  $546,244 
Other long-term liabilities   6,192,444 
Total operating lease liabilities  $6,738,688 
Weighted average remaining lease term   15.6 years 
Weighted average discount rate   7.10%

 

Supplemental balance sheet information related to finance leases is as follows:

 

   June 30, 2019 
Finance leases:     
Property and equipment, net  $1,337,917 
Current maturities of finance lease liabilities  $275,958 
Finance lease liabilities, less current portion   22,625 
Total finance lease liabilities  $298,583 
Weighted average remaining lease term   0.8 year 
Weighted average discount rate   6.13%

 

Maturities of operating and finance lease liabilities as of June 30, 2019 are as follows:

 

   Operating Leases    Finance Leases 
Due in one year or less  $997,430   $282,400 
Due after one year through two years   897,549    23,655 
Due after two years through three years   826,479    - 
Due after three years through four years   766,719    - 
Due after four years through five years   525,212    - 
Thereafter   8,010,446    - 
Total lease payments   12,023,835    306,055 
Less: Interest   (5,285,147)   (7,472)
Total  $6,738,688   $298,583 

 

  14 

 

  13. Accumulated Other Comprehensive Income (Loss)

 

The changes in accumulated other comprehensive income (loss) were as follows:

 

  Minimum
Benefit Liability
Adjustments		   Foreign Currency
Translation
Adjustment		   Total 
Balance at December 30, 2018  $836,593   $(1,539,238)  $(702,645)
                
Other comprehensive income before
reclassifications		   -    18,447    18,447 
                
Reclassification adjustment for gains included
in net income		   (147,234)   -    (147,234)
                
Balance at June 30, 2019  $689,359   $(1,520,791)  $(831,432)

 

The gains reclassified from accumulated other comprehensive income (loss) are recorded to the following line items in the Consolidated Statements of Operations:

 

Other Comprehensive Income
Component		   Statements of Operations Line
Item
     
Minimum Benefit Liability Adjustments   General and administrative expense

 

  14. Stock Based Compensation

 

On June 25, 2015, the Company’s stockholders approved the adoption of the 2015 Stock Option Plan. This plan provides for the granting of options to purchase the Company’s common stock to employees and directors. The options granted are subject to a vesting schedule as set forth in each individual option agreement. Each option expires on the tenth anniversary of its date of grant unless an earlier termination date is provided in the grant agreement. The maximum aggregate number of shares of common stock that may be optioned and sold under the plan shall be 6% of the shares outstanding on the date of grant. The shares that may be optioned under the plan may be authorized but unissued or may be treasury shares.

 

Compensation expense is recognized on a straight-line basis over a three-year vesting period from date of grant.

 

  15 

 

 Stock option activity for the six months ended June 30, 2019 and July 1, 2018 is as follows:

 

  Stock Options 
  Total   Weighted
Average
Exercise
Price		   Exercisable   Weighted
Average
Exercise
Price		   Non-
Vested		   Weighted
Average
Exercise
Price		 
Outstanding at December 31, 2017   961,500   $2.80    527,165   $2.63    434,335   $3.00 
Granted   -    -    -    -    -    - 
Vested   -    -    112,170    3.57    (112,170)   3.57 
Exercised   -    -    -    -    -    - 
Forfeited or cancelled   (15,000)   2.77    (8,334)   2.61    (6,666)   2.97 
Outstanding at July 1, 2018   946,500   $2.80    631,001   $2.80    315,499   $2.80 
                               
Outstanding at December 30, 2018   946,500   $2.80    834,335   $2.69    112,165   $3.57 
Granted   -    -    -    -    -    - 
Vested   -    -    112,165    3.57    (112,165)   3.57 
Exercised   -    -    -    -    -    - 
Forfeited or cancelled   (15,000)   2.77    (15,000)   2.77    -    - 
                               
Outstanding at June 30, 2019   931,500   $2.80    931,500   $2.80    -   $- 
                               
                               
Aggregate Intrinsic Value                              

July 1, 2018

  $-      $-        $-      
                               
Aggregate Intrinsic Value                              

June 30, 2019

  $-      $-        $-      

 

 

As of June 30, 2019 and July 1, 2018, there was no aggregate intrinsic value of the options outstanding because the options’ exercise prices of $2.37 and $3.57 per share were greater than the average market prices of the common shares.

 

Option expense recognized was $0 and $93,420 for the three months ended June 30, 2019 and July 1, 2018, respectively, and $44,166 and $193,381 for the six months ended June 30, 2019 and July 1, 2018, respectively. As of June 30, 2019, there was no unrecognized compensation cost related to the options granted under the 2015 Stock Option Plan.

 

  15. Recent Accounting Standards

 

On February 25, 2016, the Financial Accounting Standards Board issued a new standard, ASU No. 2016-02, “Leases,” on July 30, 2018, it issued ASU No. 2018-11, “Leases (Topic 842): Targeted Improvements” and on March 5, 2019, it issued ASU No. 2019-01, “Leases (Topic 842): Codification Improvements.” Under the new guidance, a lessee is required to recognize right-of-use (“ROU”) assets and lease liabilities for leases with lease terms of more than 12 months. Consistent with previous U.S. generally accepted accounting principles (“U.S. GAAP”), the recognition, measurement, and presentation of expenses and cash flows arising from a lease by a lessee primarily depends on its classification as a finance or operating lease. However, unlike previous GAAP, which required only finance leases to be recognized on the balance sheet, the new ASU requires both types of leases to be recognized on the balance sheet. The Company adopted this standard on December 31, 2018. The Company elected to recognize and measure leases at the adoption date and recognize a cumulative-effect adjustment to the opening balance of retained earnings; however, no adjustment to the opening balance of retained earnings was needed. The Company elected the available practical expedients for leases that began before the effective date of this new standard except the Company did not elect to use hindsight in determining the lease term and in assessing impairment of its ROU assets. The Company elected to apply and adopt as an accounting policy to exclude leases with terms of 12 months or less but did not elect to apply and adopt as an accounting policy not to separate lease components from non-lease components. The adoption of this standard for the year ending December 29, 2019 will have a significant effect on the Company’s consolidated financial position as it records previously unrecorded operating leases but it will not have a significant effect on its results of operations and cash flows.

 

On January 26, 2017, the Financial Accounting Standards Board issued a new standard, ASU No. 2017-04, “Intangibles – Goodwill and Other – Simplifying the Test for Goodwill Impairment.” The new standard modifies the concept of impairment from the condition that exists when the carrying amount of goodwill exceeds its implied fair value to the condition that exists when the carrying amount of a reporting unit exceeds its fair value. It will be effective for the Company on December 30, 2019. The adoption of this standard is not expected to have a significant effect on the Company’s consolidated financial position, results of operations and cash flows.

 

  16 

 

On August 28, 2018, the Financial Accounting Standards Board issued a new standard, ASU No. 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement.” The new standard modifies the disclosure requirements on fair value measurements in Topic 820, “Fair Value Measurement.” Certain requirements were removed such as the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, certain requirements were modified and certain disclosures were added such as the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period. This standard will be effective for the Company on December 30, 2019. Since this standard only revises disclosure requirements, the adoption of this standard will not have a significant effect on the Company’s consolidated financial position, results of operations and cash flows.

 

16. Earnings (Loss) per Common Share

 

The following table sets forth the computation of earnings (loss) per common share - basic and earnings (loss) per common share – diluted for the three and six months ended June 30, 2019 and July 1, 2018:

 

  Three Months Ended   Six Months Ended 
  June 30, 2019   July 1, 2018   June 30, 2019   July 1, 2018 
Numerator                
Net income (loss) allocable to
common shareholders		  $(416,899)  $148,389   $(566,341)  $(146,431)
                     
Denominator                    
Denominator for basic earnings per
share - weighted average shares
outstanding		   18,684,755    18,690,030    18,687,393    18,690,030 
Weighted average effect of dilutive
securities		   -    -    -    - 
Denominator for dilutive earnings
per share - weighted average shares
outstanding		   18,684,755    18,690,030    18,687,393    18,690,030 
                     
Basic and Diluted Income (Loss)
Per Share		                    
Net income (loss) allocable to
common shareholders		  $(0.02)  $0.01   $(0.03)  $(0.01)
Effect of dilutive securities   -    -    -    - 
Net income (loss) allocable to
common shareholders		  $(0.02)  $0.01   $(0.03)  $(0.01)

 

 

Due to the net loss for the three and six months ended June 30, 2019, the calculations of basic and diluted loss per share were the same since including options to purchase shares of common stock in the calculations of diluted loss per share would have been anti-dilutive. However, if diluted earnings per share had been reported for the three and six months ended June 30, 2019, the calculations would have excluded options to purchase 931,500 shares of common stock because the options’ exercise prices of $2.37 and $3.57 per share were greater than the average market prices of the common shares.

 

The calculation of diluted earnings per share for the three months ended July 1, 2018 excluded options to purchase 946,500 shares of common stock because the options’ exercise prices of $2.37 and $3.57 per share were greater than the average market price of the common shares.

 

Due to the net loss for the six months ended July 1, 2018, the calculations of basic and diluted loss per share were the same since including options to purchase shares of common stock in the calculation of diluted loss per share would have been anti-dilutive. However, if diluted earnings per share had been reported for the six months ended July 1, 2018, the calculation would have excluded options to purchase 946,500 shares of common stock because the options’ exercise prices of $2.37 and $3.57 per share were greater than the average market price of the common shares.

 

  17 

 

17. Revenue

 

The Company recognizes revenue and related accounts receivable when obligations under the terms of a contract with a customer are satisfied, which includes the control of products transferring to the customer. For Uniroyal, this generally occurs when products are shipped and, for UGL, this generally occurs when the customer accepts delivery either at the Company’s U.K. facility or at a mutually agreed upon location. Revenue is measured as the amount of consideration the Company expects to receive in exchange for products transferred to the customer. A contract asset occurs when an entity transfers products to a customer before payment is due while a contract liability occurs when an entity has an obligation to transfer products to a customer for which the entity has already received payment (or payment is due) from the customer. Remaining performance obligations exist when an entity expects to record future revenue on partially completed contracts. The Company does not have contract assets or contract liabilities and has no remaining performance obligations since it does not recognize revenue until a contract is complete.

 

The following table sets forth revenue disaggregated by the Company’s automotive and industrial sectors for the three and six months ended June 30, 2019 and July 1, 2018:

 

   Three Months Ended   Six Months Ended 
   June 30, 2019   July 1, 2018   June 30, 2019   July 1, 2018 
Revenue by product sector:                
Automotive sector  $15,821,277   $17,842,634   $32,300,670   $35,074,750 
Industrial sector   8,274,506    8,180,599    17,188,973    17,378,170 
Total Revenue  $24,095,783   $26,023,233   $49,489,643   $52,452,920 

 

The following table sets forth revenue disaggregated by the geographic locations of the Company’s customers for the three and six months ended June 30, 2019 and July 1, 2018:

 

   Three Months Ended   Six Months Ended 
   June 30, 2019   July 1, 2018   June 30, 2019   July 1, 2018 
Revenue by customer location:                    
North America  $11,902,854   $11,827,405   $24,314,538   $23,901,200 
Europe   10,782,170    12,811,599    22,606,670    25,164,789 
Asia   1,310,157    1,333,976    2,416,023    3,253,123 
Other   100,602    50,253    152,412    133,808 
Total Revenue  $24,095,783   $26,023,233   $49,489,643   $52,452,920 

 

  18. Restructuring Expenses

 

In order to increase operating efficiencies and decrease costs, the Company developed a plan to restructure the operations and the management team of its foreign operations located in Earby, England. As part of this restructuring, the Company announced the decommissioning of the calender operations which could not be economically modernized. An impairment charge of $510,230 for the assets used in this operation was included in the operating results for the year ended December 30, 2018. The decommissioning plan is being implemented over an extended period to permit its existing customer base time to arrange for alternate sources of product or for them to switch to one of the Company’s other coated fabric solutions from its state-of-the art production facility. The Company anticipated that it would reduce its work force but would also offer a retraining program to allow a limited number of employees the opportunity to move to other production areas within the facility. The Company does not expect that the cost associated with this aspect of the plan to be significant and will expense these costs as incurred. Also, as part of the restructuring, during the quarter ended March 31, 2019 the Company entered into settlement agreements with certain members of that facility’s management team which terminated their continuing service. The Company recorded a charge of $343,003 for the cost of these agreements which is included in Other Operating Expenses in the accompanying Consolidated Statements of Operations for the six months ended June 30, 2019.

 

  18 

 

  19. Subsequent Events

 

The Company has evaluated subsequent events occurring through the date that the financial statements were available to be issued for events requiring recording or disclosure in the June 30, 2019 consolidated financial statements. There were no material events or transactions occurring during this period requiring recognition or disclosure.

 

  19 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Business Description

 

We are a leading provider of manufactured vinyl coated fabrics. Our best-known brand, Naugahyde, is the product of many improvements on a rubber-coated fabric developed a century ago in Naugatuck, Connecticut. We design, manufacture and market a wide selection of vinyl coated fabric products under a portfolio of recognized brand names. We believe that our business has continued to be a leading supplier in its marketplace because of our ability to provide specialized materials with performance characteristics customized to the end-user specifications, complemented by technical and customer support for the use of our products in manufacturing.

 

Our vinyl coated fabric products have undergone considerable evolution and today are distinguished by superior performance in a wide variety of applications as alternatives to leather, cloth and other synthetic fabric coverings. Our standard product lines consist of more than 600 SKUs with combinations of colors, textures, patterns and other properties. Our products are differentiated by unique protective top finishes and transfer print capabilities. Additional process capabilities include embossing grains and patterns, and rotogravure printing, which imparts five color character prints and non-registered prints, lamination and panel cutting.

 

Our vinyl coated fabric products have various high-performance characteristics and capabilities. They are durable, stain resistant, easily processed, more cost-effective and better performing than traditional leather or fabric coverings. Our products are frequently used in applications that require rigorous performance characteristics such as automotive and non-automotive transportation, certain indoor/outdoor furniture, commercial and hospitality seating, healthcare facilities and athletic equipment. We manufacture materials in a wide range of colors and textures. They can be hand or machine sewn, laminated to an underlying structure, thermoformed to cover various substrates or made into a variety of shapes for diverse end-uses. We are a long-established supplier to the global automotive industry and manufacture products for interior soft trim components from floor to headliner, which are produced to meet specific component production requirements such as cut and sew, vacuum forming/covering, compression molding, and high frequency welding. Some products are supplied with micro perforations, which are necessary on most compression molding processes. Materials can also be combined with polyurethane or polypropylene foam laminated by either flame or hot melt adhesive for seating, fascia and door applications.

 

Products are developed and marketed based upon the performance characteristics required by end-users. For example, for recreational products used outdoors, such as boats, personal watercraft, golf carts and snowmobiles, a product designed primarily for water-based durability and weatherability is used. We also manufacture a line of products called BeautyGard®, with water-based topcoats that contain agents to protect against bacterial and fungal micro-organisms and can withstand repeated cleaning, a necessity in the restaurant and health care industries. These topcoats are environmentally friendlier than solvent-based topcoats. The line is widely used in hospitals and other healthcare facilities. Flame and smoke retardant vinyl coated fabrics are used for a variety of commercial and institutional furniture applications, including hospitals, restaurants and residential care centers and seats for school buses, trains and aircraft.

 

We currently conduct our operations in manufacturing facilities that are located in Stoughton, Wisconsin and Earby, England.

 

Critical Accounting Policies and Estimates

 

The preparation of our Consolidated Financial Statements and related disclosures in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make estimates and judgments that affect our reported amounts of assets and liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. On an on-going basis, we evaluate our estimates and assumptions based upon historical experience and various other factors and circumstances. We believe that our estimates and assumptions are reasonable under the circumstances; however, actual results may vary from these estimates and assumptions under different future circumstances. For further discussion of our significant accounting policies, refer to Note 1 – “Summary of Significant Accounting Policies” to the Consolidated Financial Statements and “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Policies, Judgments and Estimates” in our Annual Report on Form 10-K for the fiscal year ended December 30, 2018.

 

Recent Accounting Pronouncements

 

See Note 15 – “Recent Accounting Standards” to the Consolidated Financial Statements for a discussion of recent accounting guidance.

 

  20 

 

Overview:

 

The Company and its subsidiaries use a 52/53-week fiscal year ending on the Sunday nearest to December 31. The current year ending December 29, 2019 and the prior year ended December 30, 2018 are 52-week years.

 

Our Earby, England operation’s functional currency is the British Pound Sterling and has sales and purchases transactions that are denominated in currencies other than the Pound Sterling, principally the Euro. Approximately 29% of the Company’s global revenues and 32% of its global raw material purchases are derived from these Euro transactions.

 

The average year-to-date exchange rate for the Pound Sterling to the U.S. Dollar was approximately 6.0% lower and the average exchange rate for the Euro to the Pound Sterling was approximately 0.7% lower in 2019 compared to 2018. These exchange rate changes had the effect of decreasing net sales by approximately $1.7 million for the six months ended June 30, 2019. The overall currency effect on the Company’s net loss was a negative amount of approximately $19,000 for the six months ended June 30, 2019.

 

Three Months Ended June 30, 2019 Compared to the Three Months Ended July 1, 2018

 

The following table sets forth, for the three months ended June 30, 2019 (“three months 2019”) and July 1, 2018 (“three months 2018”), certain operations data including their respective percentage of net sales:  

 

  Three Months Ended 
  June 30, 2019   July 1, 2018   Change   %
Change		 
                               
Net Sales  $24,095,783    100.0%  $26,023,233    100.0%  $(1,927,450)   -7.4%
Cost of Sales   19,883,392    82.5%   21,259,055    81.7%   (1,375,663)   -6.5%
Gross Profit   4,212,391    17.5%   4,764,178    18.3%   (551,787)   -11.6%
Operating Expenses:                              
Selling   1,183,803    4.9%   1,200,051    4.6%   (16,248)   -1.4%
General and administrative   1,449,060    6.0%   1,658,665    6.4%   (209,605)   -12.6%
Research and development   447,754    1.9%   430,565    1.7%   17,189    4.0%
Total Operating Expenses   3,080,617    12.8%   3,289,281    12.6%   (208,664)   -6.3%
Operating Income   1,131,774    4.7%   1,474,897    5.7%   (343,123)   -23.3%
Interest expense   (523,218)   -2.2%   (473,663)   -1.8%   (49,555)   10.5%
Other expense   (224,950)   -0.9%   (19,220)   -0.1%   (205,730)   >100% 
Income before Taxes   383,606    1.6%   982,014    3.8%   (598,408)   -60.9%
Tax provision   20,559    0.1%   57,521    0.2%   (36,962)   -64.3%
Net Income   363,047    1.5%   924,493    3.6%   (561,446)   -60.7%
Preferred dividends   (779,946)   -3.2%   (776,104)   -3.0%   (3,842)   0.5%
Net Income (Loss) Allocable to
Common Shareholders		  $(416,899)   -1.7%  $148,389    0.6%  $(565,288)   <-100% 

 

 

Revenue:

 

Total revenue for the three months 2019 decreased $1,927,450 or 7.4% to $24,095,783 from $26,023,233 for the three months 2018. Excluding the negative currency effect of the exchange rates, total revenue would have only decreased by approximately $1.2 million or 4.6%. U.S. automotive sales for the three months 2019 increased 3.6% compared to the three months 2018 resulting from new automotive programs in 2019. European automotive sales decreased 11.9% compared to the prior year excluding the currency adjustment. Sales for the three months 2019 for the industrial sector increased 1.2% (2.3% before currency effect) compared to the three months 2018 as a decline in the U.S. contract market was offset by an increase in sales from the non-automotive transportation market.

 

  21 

 

Gross Profit:

 

Total gross profit for the three months 2019 decreased $551,787 or 11.6% to $4,212,391 from $4,764,178 for the three months 2018. The gross profit percentage was 17.5% of sales for the three months 2019 compared to 18.3% for the three months 2018. Gross profit amount and percentage was negatively impacted in 2019 by higher raw material prices compared to 2018 and the effects of product mix. To offset raw material price increases, the Company increased prices during the first three months of 2019 in several of its markets. The decrease in gross profit included a negative net currency effect of $123,000. Excluding this effect, gross profit would have only declined by 9.0%

 

Operating Expenses:

 

Selling expenses for the three months 2019 decreased $16,248 or 1.4% to $1,183,803 from $1,200,051 for the three months 2018. The Company pays commissions only on certain U.K. automotive programs. In conjunction with the decline in total automotive sales in the U.K. for the three months 2019, there was a decrease in commissionable sales. The decrease in selling expense for the three months 2019 was attributable to the lower commissions related to these sales. Also contributing to the decrease was the favorable currency effect of $35,000. This decrease was partially offset by increases in employment related costs.

 

General and administrative expenses for the three months 2019 decreased $209,605 or 12.6% to $1,449,060 from $1,658,665 for the three months 2018. This decrease was primarily attributable to a decrease in employment costs for the three months 2019 compared to the three months 2018. Also contributing to the decrease was the favorable currency effect of $49,000.

 

Research and development expenses for the three months 2019 increased $17,189 or 4.0% to $447,754 from $430,565 for the three months 2018. The increase was principally attributable to development costs for new trials which was partially offset by the favorable currency effect of $14,000.

 

Operating Income:

 

Operating income for the three months 2019 decreased $343,123 or 23.3% to $1,131,774 from $1,474,897 for the three months 2018. The operating income percentage was 4.7% of sales for the three months 2019 compared to 5.7% for the three months 2018. Operating income decreased from the decrease in gross profit which was partially offset by the decrease in operating expenses.

 

Interest Expense:

 

Interest expense for the three months 2019 increased $49,555 or 10.5% to $523,218 from $473,663 for the three months 2018. The increase was primarily due to new equipment purchases and higher interest rates on LIBOR and prime during the three months 2019 partially offset by debt repayments compared to the three months 2018.

 

Other Expense:

 

Other expense for the three months 2019 increased $205,730 to $224,950 from $19,220 for the three months 2018. Included in other expense are the currency gains and losses recognized on foreign currency transactions and the change in the fair value of financial assets and liabilities that are denominated in Euros as these currencies fluctuated during the quarter. Also included in other expense are gains and losses from the change in fair values on the Company’s foreign currency exchange contracts.

  

Tax Provision:

 

The Company files income tax returns in the United States as a C-Corporation, and in several state jurisdictions and in the United Kingdom. The Company’s U.S. operating subsidiary, Uniroyal, is a limited liability company (LLC) for federal and state income tax purposes and as such, its income, losses, and credits are allocated to its members. The Company made the acquisition of Uniroyal through UEPH, a limited liability company, which issued preferred ownership interests to the sellers that provide for quarterly dividends. Uniroyal’s taxable income is allocated entirely to UEPH as its sole member and since it is a pass-through entity, this income less the dividends paid to the sellers of Uniroyal is reported on the Company’s tax return. The taxable income applicable to the dividends for the preferred ownership interests is reported to the sellers who report it on their respective individual tax returns.

 

For the three months 2019, the tax provision was $20,559 as compared to $57,521 for the three months 2018. The lower provision is due to a decrease in taxable income in the U.K.

 

  22 

 

Preferred Stock Dividend:

 

The terms of the acquisitions in November 2014 resulted in the issuance of preferred ownership units/stock of UEP Holdings, LLC and UGEL (formerly EPAL) to the sellers. These preferred units have carried quarterly dividend requirements on a total value of $55,000,000 at rates ranging from 5.0% to 7.5%. The dividend rate on the Series B UEP Holdings preferred units which started at 5.5% increases by 0.5% on the anniversary of the issuance up to a maximum of 8.0%.

 

Six Months Ended June 30, 2019 Compared to the Six Months Ended July 1, 2018

 

The following table sets forth, for the six months ended June 30, 2019 (“six months 2019”) and July 1, 2018 (“six months 2018”), certain operations data including their respective percentage of net sales: 

 

  Six Months Ended 
  June 30, 2019   July 1, 2018   
Change		   %
Change		 
Net Sales  $49,489,643    100.0%  $52,452,920    100.0%  $(2,963,277)   -5.6%
Cost of Sales   40,963,050    82.8%   43,071,248    82.1%   (2,108,198)   -4.9%
Gross Profit   8,526,593    17.2%   9,381,672    17.9%   (855,079)   -9.1%
Operating Expenses:                              
Selling   2,286,841    4.6%   2,549,081    4.9%   (262,240)   -10.3%
General and administrative   2,959,860    6.0%   3,606,966    6.9%   (647,106)   -17.9%
Research and development   924,718    1.9%   852,528    1.6%   72,190    8.5%
Other operating expenses   343,003    0.7%   -    0.0%   343,003    - 
Total Operating Expenses   6,514,422    13.2%   7,008,575    13.4%   (494,153)   -7.1%
Operating Income   2,012,171    4.1%   2,373,097    4.5%   (360,926)   -15.2%
Interest expense   (1,037,514)   -2.1%   (930,027)   -1.8%   (107,487)   11.6%
Other income   3,183    0.0%   14,062    0.0%   (10,879)   -77.4%
Income before Taxes   977,840    2.0%   1,457,132    2.8%   (479,292)   -32.9%
Tax provision (benefit)   (18,309)   0.0%   43,000    0.1%   (61,309)   <-100% 
Net Income   996,149    2.0%   1,414,132    2.7%   (417,983)   -29.6%
Preferred dividends   (1,562,490)   -3.2%   (1,560,563)   -3.0%   (1,927)   0.1%
Net Loss Allocable to Common Shareholders  $(566,341)   -1.1%  $(146,431)   -0.3%  $(419,910)   >100% 

 

Revenue:

 

Total revenue for the six months 2019 decreased $2,963,277 or 5.6% to $49,489,643 from $52,452,920 for the six months 2018. Excluding the negative currency effect of the exchange rates, total revenue would have only decreased by approximately $1.2 million or 2.3%. U.S. automotive sales for the six months 2019 increased 3.0% compared to the six months 2018 as a result of new automotive programs in 2019. European automotive sales decreased 6.4% compared to the prior year excluding the currency adjustment. Sales for the six months 2019 for the industrial sector decreased 1.1% (or a marginal increase of 0.1% before currency effect) compared to the six months 2018 as a decline in the U.S. contract market was partially offset by an increase in sales from the non-automotive transportation market.

 

Gross Profit:

 

Total gross profit for the six months 2019 decreased $855,079 or 9.1% to $8,526,593 from $9,381,672 for the six months 2018. The gross profit percentage was 17.2% of sales for the six months 2019 compared to 17.9% for the six months 2018. Gross profit amount and percentage was negatively impacted in 2019 by higher raw material prices compared to 2018 and the effects of product mix. To offset raw material price increases, the Company increased prices during the first three months of 2019 in several of its markets. The decrease in gross profit included a negative net currency effect of $275,000. Excluding this effect, gross profit would have only declined by 6.2%

 

  23 

  

Operating Expenses:

 

Selling expenses for the six months 2019 decreased $262,240 or 10.3% to $2,286,841 from $2,549,081 for the six months 2018. The Company pays commissions only on certain U.K. automotive programs. In conjunction with the decline in total automotive sales in the U.K. for the six months 2019, there was a decrease in commissionable sales. The decrease in selling expense for the six months 2019 was principally attributable to the lower commissions related to these sales. Also contributing to the decrease was the favorable currency effect of $80,000. This decrease was partially offset by increases in employment related costs.

 

General and administrative expenses for the six months 2019 decreased $647,106 or 17.9% to $2,959,860 from $3,606,966 for the six months 2018. This decrease was primarily attributable to a decrease in employment costs for the six months 2019 compared to the six months 2018. Also contributing to the decrease was the favorable currency effect of $109,000.

 

Research and development expenses for the six months 2019 increased $72,190 or 8.5% to $924,718 from $852,528 for the six months 2018. The increase was principally attributable to development costs for new trials which was partially offset by the favorable currency effect of $32,000.

 

Other operating expenses for the six months 2019 was $343,003. There was not a corresponding amount for the six months 2018. This amount is cost incurred by the Company as part of a restructuring plan to reduce inefficiencies at its U.K. facility.

 

Operating Income:

 

Operating income for the six months 2019 decreased $360,926 or 15.2% to $2,012,171 from $2,373,097 for the six months 2018. The operating income percentage was 4.1% of sales for the six months 2019 compared to 4.5% for the six months 2018. Operating income decreased from the decrease in gross profit which was partially offset by the decrease in operating expenses.

 

Interest Expense:

 

Interest expense for the six months 2019 increased $107,487 or 11.6% to $1,037,514 from $930,027 for the six months 2018. The increase was primarily due to new equipment purchases and higher interest rates on LIBOR and prime during the six months 2019 partially offset by debt repayments compared to the six months 2018.

 

Other Income:

 

Other income for the six months 2019 decreased $10,879 to $3,183 from $14,062 for the six months 2018. Included in other income are the currency gains and losses recognized on foreign currency transactions and the change in the fair value of financial assets and liabilities that are denominated in Euros as these currencies fluctuated during the year. Also included in other income are gains and losses from the change in fair values on the Company’s foreign currency exchange contracts.

  

Tax Provision (Benefit):

 

The Company files income tax returns in the United States as a C-Corporation, and in several state jurisdictions and in the United Kingdom. The Company’s subsidiary, Uniroyal, is a limited liability company (LLC) for federal and state income tax purposes and as such, its income, losses, and credits are allocated to its members. The Company made the acquisition of Uniroyal through UEPH, a limited liability company, which issued preferred ownership interests to the sellers that provide for quarterly dividends. Uniroyal’s taxable income is allocated entirely to UEPH as its sole member and since it is a pass-through entity, this income less the dividends paid to the sellers of Uniroyal is reported on the Company’s tax return. The taxable income applicable to the dividends for the preferred ownership interests is reported to the sellers who report it on their respective individual tax returns.

 

For the six months 2019, the tax benefit was $18,309 as compared to a tax provision of $43,000 for the six months 2018. The tax benefit for 2019 and the tax provision for 2018 were principally attributable to the results of the U.K. operations.

 

Preferred Stock Dividend:

 

The terms of the acquisitions in November 2014 resulted in the issuance of preferred ownership units/stock of UEP Holdings, LLC and UGEL (formerly EPAL) to the sellers. These preferred units have carried quarterly dividend requirements on a total value of $55,000,000 at rates ranging from 5.0% to 7.5%. The dividend rate on the Series B UEP Holdings preferred units which started at 5.5% increases by 0.5% on the anniversary of the issuance up to a maximum of 8.0%.

 

  24 

 

Liquidity and Sources of Capital

 

Cash, as it is needed, is provided by using the Company’s lines of credit. These lines provide for a total borrowing commitment in excess of $42,000,000 subject to the underlying borrowing base specified in the agreements. Of the total outstanding borrowings of $21,196,050 at June 30, 2019, $15.2 million of the lines bears interest at LIBOR or the Eurodollar rate plus a range of 1.95% to 2.45%, depending on the underlying borrowing base and $6 million bears interest at the bank’s prime or base lending rate which was 5.5% at June 30, 2019. At June 30, 2019, the lines provided an additional availability of approximately $2.1 million. We plan to use this availability and cash provided by operating activities to finance our cash needs for the remaining months of fiscal 2019 and future periods. The balances due under the lines of credit are recorded as current liabilities on the Consolidated Balance Sheets.

 

Given our capital resources in the U.S. and the potential for increased investment and acquisitions in foreign jurisdictions, we did not have a history of repatriating a significant portion of our foreign cash. Accordingly, we had not recognized a deferred tax liability for these unremitted earnings. However, the Tax Cuts and Jobs Act of 2017 imposed a one-time transition tax on deemed repatriation of deferred foreign income, which the Company recorded in tax expense in 2017. In the event that we decide to repatriate these foreign amounts to fund U.S. operations, the Company will not be required to pay any additional U.S. tax related to these amounts.

 

The ratio of current assets to current liabilities, including the amount due under our lines of credit, was 0.94 at June 30, 2019 and 0.97 at December 30, 2018.

 

Cash balances decreased $309,344 before the effects of currency translation of $4,701, to $724,198 at June 30, 2019 from $1,028,841 at December 30, 2018. Of the above noted amounts, $694,432 and $923,071 were held outside the U.S. by our foreign subsidiaries as of June 30, 2019 and December 30, 2018, respectively.

 

Cash provided by operations was $805,473 for the six months 2019 compared to $2,067,906 provided by operations for the six months 2018. For the six months 2019, cash provided by operations was primarily due to adjustments for non-cash items of $1,109,420, net income of $996,149 and changes in other assets and liabilities of $41,131 offset by changes in working capital of $(1,341,227). For the six months 2018, cash provided by operations was primarily due to net income of $1,414,132 and adjustments for non-cash items of $1,214,211 offset by cash flows related to changes in working capital of $(478,858) and changes in other assets and liabilities of $(81,579).

 

Cash used in investing activities was $826,643 for the six months 2019 compared to $1,383,284 for the six months 2018. During 2019 and 2018, cash used in investing activities was principally for purchases of machinery and equipment at our manufacturing locations and payments made for company-owned key man life insurance premiums.

 

For the six months 2019, cash used in financing activities was $288,174 as compared to $1,041,081 used in financing activities for the six months 2018. Impacting cash flows from financing activities for the six months 2019 and 2018 were net advances on lines of credit of $1,707,469 and $389,712, respectively. The increases in advances on the lines of credit were used to fund working capital. Also included in cash flows from financing activities were preferred dividend payments of $1,560,822 and $1,553,806 during the six months 2019 and 2018, respectively. During the six months 2019 and 2018, our majority shareholder provided $200,000 and $272,000, respectively, in financing in the form of subordinated secured promissory notes. During the six months 2018, we drew $486,067 on an equipment financing commitment from our bank to finance asset purchases.

 

Our credit agreements contain customary affirmative and negative covenants. We were in compliance with our debt covenants as of June 30, 2019 and through the date of filing of this report.

 

We currently have several on-going capital projects that are important to our long-term strategic goals. Machinery and equipment will also be added as needed to increase capacity or enhance operating efficiencies in our manufacturing plants. We will use a combination of financing arrangements to provide the necessary capital. We believe that our existing resources, including cash on hand and our credit facilities, together with cash generated from operations and additional bank borrowings, will be sufficient to fund our cash flow requirements through at least the next twelve months. However, there can be no assurance that additional financing will be available on favorable terms, if at all.

 

We have no material off balance sheet arrangements.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

Not applicable.

 

  25 

 

Item 4. Controls and Procedures

 

The Company maintains “disclosure controls and procedures” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), that are designed to ensure that information required to be disclosed by us in reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer, Chief Financial Officer, and Board of Directors, as appropriate, to allow timely decisions regarding required disclosures. In designing and evaluating our disclosure controls and procedures, management recognizes that disclosure controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired objectives, and we necessarily are required to apply our judgment in evaluating the cost-benefit relationship of possible disclosure controls and procedures.

 

Our management, including our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of June 30, 2019 and concluded that our disclosure controls and procedures were effective as of June 30, 2019.

 

Changes in Internal Controls over Financial Reporting

 

During the six months ended June 30, 2019, there were no changes in the Company’s internal control over financial reporting (as defined in Rule 13a-15(f) and 15d-15(f) under the Exchange Act) that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

  26 

 

PART II.  OTHER INFORMATION

 

Item 1. Legal Proceedings

 

None.

 

Item 1A. Risk Factors

 

Not applicable.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

Issuer Purchases of Equity Securities

 

Second Quarter 2019
For the Period  Total
number of
shares
purchased		  Average
price
paid per
share		  Total
number of
shares
purchased
as part of
publicly
announced
plans or
programs		  Maximum
number (or
approximate
dollar value)
of shares that
may yet be
purchased
under the
plans or
programs
                 
April 1, 2019 to April 28, 2019   -  $-   -   -
April 29, 2019 to May 26, 2019   10,000  $1.33   -   -
May 27, 2019 to June 30, 2019   -  $-   -   -
Total   10,000  $1.33   -   -

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

Not applicable.

 

Item 5. Other Information

 

None.

 

  27 

 

Item 6. Exhibits

 

(a) Exhibits.

 

Exhibit No.   Description
     
31.1 *   Chief Executive Officer Certification Pursuant to Securities Exchange Act Rules 13a-14(a)
31.2 *   Chief Financial Officer Certification Pursuant to Securities Exchange Act Rules 13a-14(a)
32.1 *   Chief Executive Officer Certification Pursuant to 18 U.S.C. Section 1350
32.2 *   Chief Financial Officer Certification Pursuant to 18 U.S.C. Section 1350
101.INS * +   XBRL Instance Document
101.CAL * +   XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF * +   XBRL Taxonomy Extension Definition Linkbase Document
101.LAB * +   XBRL Taxonomy Extension Label Linkbase Document
101.PRE * +   XBRL Taxonomy Extension Presentation Linkbase Document
101.SCH * +   XBRL Taxonomy Extension Schema Document

_______________

* Filed herewith.

 

+ In accordance with Rule 406T of Regulation S-T, this information is deemed not “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

 

 

Signatures

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  UNIROYAL GLOBAL ENGINEERED PRODUCTS, INC.  
       
       
Dated:   August 5, 2019 By: /s/  Howard R. Curd  
   

Howard R. Curd

Chief Executive Officer

  
       

 

Dated:   August 5, 2019 By: /s/  Edmund C. King  
   

Edmund C. King

Chief Financial Officer

  
       

 

 

28